These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

212 related items for PubMed ID: 12559845

  • 1. Visceral obesity attenuates the effect of the hepatic lipase -514C>T polymorphism on plasma HDL-cholesterol levels in French-Canadian men.
    St-Pierre J, Miller-Felix I, Paradis ME, Bergeron J, Lamarche B, Després JP, Gaudet D, Vohl MC.
    Mol Genet Metab; 2003 Jan; 78(1):31-6. PubMed ID: 12559845
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Hepatic lipase gene variant -514C>T is associated with lipoprotein and insulin sensitivity response to regular exercise: the HERITAGE Family Study.
    Teran-Garcia M, Santoro N, Rankinen T, Bergeron J, Rice T, Leon AS, Rao DC, Skinner JS, Bergman RN, Després JP, Bouchard C, HERITAGE Family Study.
    Diabetes; 2005 Jul; 54(7):2251-5. PubMed ID: 15983229
    [Abstract] [Full Text] [Related]

  • 6. The MspI polymorphism of the apolipoprotein A-II gene as a modulator of the dyslipidemic state found in visceral obesity.
    Vohl MC, Lamarche B, Bergeron J, Moorjani S, Prud'homme D, Nadeau A, Tremblay A, Lupien PJ, Bouchard C, Després JP.
    Atherosclerosis; 1997 Feb 10; 128(2):183-90. PubMed ID: 9050775
    [Abstract] [Full Text] [Related]

  • 7. Hepatic lipase gene -514 C/T polymorphism and premature coronary heart disease.
    Ji J, Herbison CE, Mamotte CD, Burke V, Taylor RR, van Bockxmeer FM.
    J Cardiovasc Risk; 2002 Apr 10; 9(2):105-13. PubMed ID: 12006918
    [Abstract] [Full Text] [Related]

  • 8. The -514C>T polymorphism in the LIPC gene modifies type 2 diabetes risk through modulation of HDL-cholesterol levels in Mexicans.
    Guerra-García MT, Moreno-Macías H, Ochoa-Guzmán A, Ordoñez-Sánchez ML, Rodríguez-Guillen R, Vázquez-Cárdenas P, Ortíz-Ortega VM, Peimbert-Torres M, Aguilar-Salinas CA, Tusié-Luna MT.
    J Endocrinol Invest; 2021 Mar 10; 44(3):557-565. PubMed ID: 32617858
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Genetic variation in the hepatic lipase gene is associated with combined hyperlipidemia, plasma lipid concentrations, and lipid-lowering drug response.
    Cenarro A, Artieda M, Gonzalvo C, Meriño-Ibarra E, Arístegui R, Gañán A, Díaz C, Sol JM, Pocoví M, Civeira F, ATOMIX Study Group.
    Am Heart J; 2005 Dec 10; 150(6):1154-62. PubMed ID: 16338252
    [Abstract] [Full Text] [Related]

  • 13. Associations between HDL-cholesterol and polymorphisms in hepatic lipase and lipoprotein lipase genes are modified by dietary fat intake in African American and White adults.
    Nettleton JA, Steffen LM, Ballantyne CM, Boerwinkle E, Folsom AR.
    Atherosclerosis; 2007 Oct 10; 194(2):e131-40. PubMed ID: 17157861
    [Abstract] [Full Text] [Related]

  • 14. Absence of association between genetic variation in the LIPC gene promoter and plasma lipoproteins in three Canadian populations.
    Hegele RA, Harris SB, Brunt JH, Young TK, Hanley AJ, Zinman B, Connelly PW.
    Atherosclerosis; 1999 Sep 10; 146(1):153-60. PubMed ID: 10487498
    [Abstract] [Full Text] [Related]

  • 15. Hepatic lipase gene -514C>T variant is associated with exercise training-induced changes in VLDL and HDL by lipoprotein lipase.
    Brinkley TE, Halverstadt A, Phares DA, Ferrell RE, Prigeon RL, Hagberg JM, Goldberg AP.
    J Appl Physiol (1985); 2011 Dec 10; 111(6):1871-6. PubMed ID: 21960661
    [Abstract] [Full Text] [Related]

  • 16. Joint linkage and association analysis of the hepatic lipase promoter polymorphism and lipoprotein size phenotypes.
    Almasy L, Rainwater DL, Cole S, Mahaney MC, Vandeberg JL, Hixson JE, Stern MP, MacCluer JW, Blangero J.
    Hum Biol; 2005 Feb 10; 77(1):17-25. PubMed ID: 16114813
    [Abstract] [Full Text] [Related]

  • 17. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men.
    Talmud PJ, Hawe E, Robertson K, Miller GJ, Miller NE, Humphries SE.
    Ann Hum Genet; 2002 Mar 10; 66(Pt 2):111-24. PubMed ID: 12174215
    [Abstract] [Full Text] [Related]

  • 18. Relation of the -514C/T polymorphism in the hepatic lipase gene to serum HDL and LDL cholesterol levels in postmenopausal women under hormone replacement therapy.
    Yamakawa-Kobayashi K, Somekawa Y, Fujimura M, Tomura S, Arinami T, Hamaguchi H.
    Atherosclerosis; 2002 May 10; 162(1):17-21. PubMed ID: 11947893
    [Abstract] [Full Text] [Related]

  • 19. Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study.
    Després JP, Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Bouchard C.
    Arterioscler Thromb Vasc Biol; 2000 Aug 10; 20(8):1932-8. PubMed ID: 10938014
    [Abstract] [Full Text] [Related]

  • 20. The lipoprotein lipase HindIII polymorphism modulates plasma triglyceride levels in visceral obesity.
    Vohl MC, Lamarche B, Moorjani S, Prud'homme D, Nadeau A, Bouchard C, Lupien PJ, Després JP.
    Arterioscler Thromb Vasc Biol; 1995 May 10; 15(5):714-20. PubMed ID: 7749885
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.